enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Insulin degludec - Wikipedia

    en.wikipedia.org/wiki/Insulin_degludec

    Insulin degludec is an ultra-long acting insulin that, unlike insulin glargine, is active at a physiologic pH.The addition of hexadecanedioic acid via an amide linkage to lysine at the B29 position allows for the formation of multi-hexamers in subcutaneous tissues. [16]

  3. Insulin degludec/liraglutide - Wikipedia

    en.wikipedia.org/wiki/Insulin_degludec/liraglutide

    Insulin degludec/liraglutide, sold under the brand name Xultophy, is a fixed-dose combination medication for the treatment of adults with type 2 diabetes to improve glycemic control in combination with diet and exercise. [7] [8] It contains insulin degludec and liraglutide. [7] [8] It is administered by subcutaneous injection. [7] [8]

  4. Insulin (medication) - Wikipedia

    en.wikipedia.org/wiki/Insulin_(medication)

    2006 Novo Nordisk Levemir "detemir" insulin analogue approved for clinical use in the US. 2008 Abott laboratories" FreeStyle Navigator CGM" gets approved. [93] 2013 The US Food and Drug Administration (FDA) requested more cardiac safety tests for Insulin degludec. 2015 Insulin degludec was approved by the FDA in September 2015.

  5. FDA advisers weigh benefits of weekly insulin for people with ...

    www.aol.com/fda-advisers-weigh-benefits-weekly...

    Most types of insulin therapy, an important part of diabetes treatment for many people, are given as daily injections to help manage blood sugar levels. Now, the maker of a once-weekly insulin ...

  6. Fast-acting, inhaled insulin Afrezza approved by F.D.A. - AOL

    www.aol.com/article/2014/06/29/fast-acting...

    The U.S. Food and Drug Administration has approved a fast-acting diabetes drug called Afrezza for use by adults with Type 1 or Type 2 diabetes. The drug is inhaled into the lungs using a small ...

  7. Novo Nordisk's Once-Weekly Insulin Flagged With Risk Of ... - AOL

    www.aol.com/finance/novo-nordisks-once-weekly...

    The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee is scheduled to meet on May 24 to review Novo Nordisk A/S’s (NYSE:NVO) application seeking approval for a once-weekly insulin ...

  8. GLP-1 receptor agonist - Wikipedia

    en.wikipedia.org/wiki/GLP-1_receptor_agonist

    The FDA has not approved GLP-1 agonists for type 1 diabetes, but they can be used off-label in addition to insulin to help type 1 diabetes patients improve their body weight and glucose control. [ 8 ]

  9. Inhalable insulin - Wikipedia

    en.wikipedia.org/wiki/Inhalable_insulin

    In January 2006, the U.S. Food and Drug Administration (FDA) approved the use of Exubera, a form of inhalable insulin developed by Pfizer. [3] It was approved in the UK in August 2006 but reimbursed by the National Health Service only for people who had problems with needles. [8] It was not reimbursed by any US insurer. [9]